505 ODYSSEY WAY, EXPLORATION PARK, FL
Announces Intention to Voluntarily Delist and Deregister its Class A Common Stock
Material disclosure
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Changes in Board, Management or Compensation
Appoints Peter Powchik, M.D., to Executive Vice President, Global Scientific Director
Shareholder votes
Annual Report to Security Holders
FY 2023 amended
FY 2023
Q3
Q2
Q1
FY 2022
Notice of Suspension of Duty to File Reports
Effectiveness Notice
SEC Form 25 - Delisting Notification
Prospectus filed pursuant to Rule 424(b)(3)
Registration Statement for Securities Offered under a Shelf Registration
Registration Statement for Securities to be Offered to Employees
Definitive Information Statement
Preliminary Information Statement
Additional Proxy Materials
Definitive Proxy Statement
Statement of Changes in Beneficial Ownership
Amended Schedule 13G - Ownership Report
Notice of Proposed Sale of Securities
S-8 POS
Post-Effective Amendment to Registration Statement
Correspondence
Submission Upload